Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search